Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

ProRx LLC recalls TIRZEPATIDE 60 mg/3mL (20/mg/mL)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • TIRZEPATIDE 60 mg/3mL (20/mg/mL)
Company
ProRx LLC
Where it was sold

Nationwide in the USA

Nationwide

Units affected
1,732 vials
About this recall
TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02